Aditya H. Gaur

机构：St. Jude Children's Research Hospital, Somerset Partnership NHS Foundation Trust · ORCID：0000-0002-6639-5231

发表论文 186 篇 · 总被引 7829 次 · h-index 43

代表论文

• Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons (2024 · New England Journal of Medicine · 被引 261)
• Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study (2024 · The Lancet HIV · 被引 30)
• Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study (2024 · The Lancet HIV · 被引 26)
• Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial (2024 · Nature Communications · 被引 21)
• Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study (2024 · The Lancet HIV · 被引 13)
• TIRTL-seq: deep, quantitative and affordable paired TCR repertoire sequencing (2025 · Nature Methods · 被引 12)